Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 CFR Part 201, Subpart A—General Labeling Provisions
21 CFR Part 201, Subpart A—General Labeling Provisions, “General Labeling Provisions”, is a CFR division of 21 CFR Part 201—Labeling.
https://ontology.bommaritollc.com/id/01a0f094-b5a0-730a-8f1e-9edc8b8a21e6
Elsewhere
Facts
| adms:identifier | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 CFR Part 201, Subpart A |
| schema:legislationJurisdiction | |
| schema:legislationType | |
| schema:name | General Labeling Provisionsen |
| skos:prefLabel | 21 CFR Part 201, Subpart A—General Labeling Provisionsen |
Related
Parts (17)schema:isPartOf
- 21 CFR 201.1 Drugs; name and place of business of manufacturer, packer, or distributor.
- 21 CFR 201.10 Drugs; statement of ingredients.
- 21 CFR 201.15 Drugs; prominence of required label statements.
- 21 CFR 201.16 Drugs; Spanish-language version of certain required statements.
- 21 CFR 201.17 Drugs; location of expiration date.
- 21 CFR 201.18 Drugs; significance of control numbers.
- 21 CFR 201.19 Drugs; use of term “infant”.
- 21 CFR 201.2 Drugs and devices; National Drug Code numbers.
- 21 CFR 201.20 Declaration of presence of FD&C Yellow No. 5 and/or FD&C Yellow No. 6 in certain drugs for human use.
- 21 CFR 201.21 Declaration of presence of phenylalanine as a component of aspartame in over-the-counter and prescription drugs for human use.
- 21 CFR 201.22 Prescription drugs containing sulfites; required warning statements.
- 21 CFR 201.23 Required pediatric studies.
- 21 CFR 201.24 Labeling for systemic antibacterial drug products.
- 21 CFR 201.25 Bar code label requirements.
- 21 CFR 201.26 Exceptions or alternatives to labeling requirements for human drug products held by the Strategic National Stockpile.
- 21 CFR 201.5 Drugs; adequate directions for use.
- 21 CFR 201.6 Drugs; misleading statements.